Fluconazole is the highest-priority interaction: it inhibits cytochrome P450 enzymes and causes clinically significant phenobarbital (PB) accumulation, producing sedation, ataxia, and elevated liver enzymes consistent with PB toxicity. A baseline serum PB concentration should be obtained before starting fluconazole, with reassessment 7–10 days after initiation and close monitoring for toxicity signs; PB dose reduction is warranted if concentrations rise above the therapeutic target of 15–35 mcg/mL (trough) in dogs.Journal of Vete…+1
Phenobarbital induces hepatic CYP enzymes and accelerates the clearance of levetiracetam (LEV), requiring substantially higher LEV doses to achieve therapeutic concentrations. Using the relationship quantified in epileptic dogs — serum LEV concentration = −1.92 × PB oral dose + 0.03 × LEV oral dose + 26.96 — a dog receiving a mean PB dose of 7 mg/kg/day would require a starting LEV dose of approximately 216 mg/kg/day (72 mg/kg q8h) to achieve a serum concentration of at least 20 mcg/mL.Journal of Vete… The extended-release LEV formulation shows the same interaction, with PB co-administration increasing apparent oral clearance and volume of distribution while reducing peak concentration and area under the curve.Journal of Vete… Dogs on PB receiving LEV should be started at higher-than-standard doses, with dose escalation guided by clinical response.
Cannabidiol (CBD) does not produce a pharmacokinetic interaction with PB at a dose of 10 mg/kg — no dose adjustment of either drug is needed based on PK data alone. No significant differences in PB pharmacokinetic variables were found when PB (4 mg/kg) was administered with or without CBD (10 mg/kg).American Journa… However, chronic CBD administration at 10–20 mg/kg/day causes elevated alkaline phosphatase (ALP) in dogs (reported range 301–978 U/L) and hyporexia, and at higher doses in combination with other antiseizure medications, elevations in alanine transferase (ALT) and bile acid concentrations have been observed, raising concern for hepatic injury.American Journa…+1 Liver enzyme monitoring is warranted when CBD is used alongside PB.
PB itself is a potent autoinducer of its own hepatic metabolism, progressively shortening its elimination half-life with chronic administration (half-life range 37–75 hours, mean 53 hours at steady state).MSD Vet Manuals This autoinduction means that PB doses adequate at initiation may become subtherapeutic over time; serum concentrations should be rechecked 2–3 weeks after any dose change and every 6–12 months during maintenance.MSD Vet Manuals Body weight and age are significant covariates on apparent clearance, supporting individualized dosing.Frontiers in Ve…
When PB is combined with potassium bromide (KBr) at 15–30 mg/kg PO q24h, adverse effects including ataxia, lethargy, polyuria, and polydipsia are exacerbated compared to either drug alone.MSD Vet Manuals This combination remains effective for refractory epilepsy but requires monitoring for additive sedation and electrolyte effects.
Imepitoin combined with PB is a viable option for drug-resistant idiopathic epilepsy, with a ≥50% reduction in monthly seizure frequency achieved in 36–42% of dogs across treatment cohorts.BMC Veterinary… A starting imepitoin dose of 5 mg/kg PO q12h (titrated to a mean of 15 mg/kg q12h) is better tolerated than 10 mg/kg q12h and is associated with fewer cases of seizure aggravation.BMC Veterinary… Seizure aggravation occurred primarily at the higher starting dose, particularly in dogs also receiving potassium bromide or levetiracetam.BMC Veterinary…
| Drug | Interaction with PB | Dosing Adjustment | Key Caveat |
|---|---|---|---|
| Fluconazole | CYP inhibition → ↑ PB concentrations → toxicity | Reduce PB dose; recheck levels 7–10 days after starting fluconazole | Baseline PB level required before initiating fluconazole Journal of Vete… |
| Levetiracetam (IR/XR) | PB induces LEV clearance → ↓ LEV concentrations | Starting dose ~72 mg/kg q8h needed to reach ≥20 mcg/mL at mean PB dose of 7 mg/kg/day | Therapeutic LEV target of 20 mcg/mL is extrapolated from human data Journal of Vete… |
| Cannabidiol | No significant PK interaction at 10 mg/kg | No PK-based dose adjustment needed | Chronic CBD causes ALP elevation (301–978 U/L); monitor liver enzymes American Journa…+1 |
| Potassium bromide | Additive CNS/renal adverse effects | Use KBr 15–30 mg/kg PO q24h; reduce if ataxia/sedation emerge | Loading dose (100 mg/kg PO q24h × 4–6 days) carries aspiration risk MSD Vet Manuals |
| Imepitoin | Additive GABAergic effect; combination is clinically useful | Start imepitoin at 5 mg/kg PO q12h; titrate as needed | Cluster seizure activity predicts drug resistance regardless of combination BMC Veterinary… |
Would you like guidance on therapeutic drug monitoring intervals and target trough concentrations when adjusting PB doses after adding one of these interacting drugs?